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Styrene-7,8-oxide (SO), the main intermediate metabolite of
styrene, induces hyperkeratosis and tumors in the fore-
stomach of rats and mice upon chronic administration by
gavage. The aim of this study was to investigate whether
DNA binding could be responsible for the carcinogenic effect
observed. [7?H]SO was administered by oral gavage in corn
oil to male CD rats at two dose levels (1.65 or 240 mg/kg).
After 4 or 24 h, forestomach, glandular stomach and liver
were excised, DNA was isolated and its radioactivity
determined. At the 4 h time point, the DNA radioactivity was
below the limit of detection in the forestomach and the liver.
Expressed in the units of the covalent binding index, CBI =
(/unol adduct/mol DNA nucleotide)/(mmol chemical
administered/kg body wt), the DNA-binding potency was
below 2.6 and 2.0 respectively. In the glandular stomach at
4 h, and in most 24 h samples, DNA was slightly radiolabeled.
Enzymatic degradation of the DNA and separation by HPLC
of the normal nucleotides showed that the DNA radioactivity
represented biosynthetic incorporation of radiolabel into
newly synthesized DNA. The limit of detection of DNA
adducts in the glandular stomach was 1.0. In a second
experiment, [T-TIISO was administered by i.p. injection to
male B6C3F1 mice. Liver DNA was analyzed after 2 h. No
radioactivity was detectable at a limit of detection of CBI
< 0.6. In agreement with the relatively long half-life of SO
in animals, the chemical reactivity of SO appears to be too
low to result in a detectable production of DNA adducts in
an in vivo situation. Upon comparison with the DNA-binding
of other carcinogens, a purely genotoxic mechanism of
tumorigenic action of SO is unlikely. The observed
tumorigenic potency in the forestomach could be the result
of strong tumor promotion by high-dose cytotoxkity followed
by regenerative hyperplasia.
Introduction
Styrene is a widely used plastic monomer. Exposure of humans
occurs at the workplace and, at a much lower level, from polluted
air and monomer residues in polystyrene (1). Because of the
structural similarity with the carcinogen vinyl chloride, the
carcinogenic potential of styrene was examined. An IARC
Working group concluded that styrene is possibly carcinogenic
to humans (2). This classification was based on inadequate
evidence for carcinogenicity to humans and on limited evidence
for carcinogenicity to animals, hi the latter, organs with high
spontaneous tumor incidence appeared to be affected (mouse: lung
and liver). The overall classification of styrene was also based
•Abbreviations: SO, styrene-7,8-oxide; HA, hydroxyapatite; CBI, covalent
binding index.
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on the sufficient evidence for the carcinogenicity of
styrene-7,8-oxide (SO*), the major intermediate metabolite
in vivo: with oral gavage of SO, forestomach tumors were
induced in both rats and mice (3-5).
The genetic toxicology of styrene and SO has been reviewed
recently (6). SO was mutagenic in a number of test systems
without metabolic activation. DNA adduct formation in vitro has
also been investigated extensively by Hemminki and co-workers
(7, and references therein). In vivo, only one publication reports
on the identification of a guanyl-7 adduct in liver DNA isolated
from mice after i.p. administration of tritiated SO (8). A
quantitative analysis of the overall DNA-binding potency of SO
is not possible, however, on the basis of tfifese results.
SO is a relatively stable epoxide. The half-life of SO in the
blood is ~20 min in the rat (9). This means that the reaction
with the weak nucleophilic centers in DNA must be slow. On
the other hand, binding to nucleophilic groups in proteins is
expected to be more rapid. Protein binding would also explain
the cytotoxicity and regenerative hyperplasia that accompany
tumor induction by SO in the forestomach. Since stimulation of
cell division is known to be a strong promoting factor in
carcinogenesis (10), it is not known to what extent tumor
induction in the forestomach was due to DNA binding.
In this study, the covalent binding of tritiated SO to DNA is
investigated in vivo and the data are analyzed in terms of a DNA-
binding potency. On the basis of a comparison with odier
carcinogens, die contribution of DNA binding to the tumorigenic
potency of SO in the forestomach is evaluated.
Materials and methods
Chemicals
[7-3H]Styrene-7,8-oxide (mol. wt 120.15) was purchased from The
Radiochemical Centre, Amersham, UK. The specific activity was 105 mCi/mmol
(0.875 mCi/mg). It was stored at -20°C and used within 2 months after delivery.
The radiochemical purity of the compound in the application solution was checked
by HPLC on a 250 x 8 mm column, filled with Lichrosorb RP18 7 /i, with
a distilled water/acetonitrile gradient (0 min: 30% acetonitrile, 60 min: 100%
acetonitrile), at a flow rate of 3.5 ml/min. A solution of styrene/SO/styrene glycol
(1:4:4) in acetonitrile was injected as standard. The radiochemical purity was
determined to be 93.2%.
SO, DMSO, and calf thymus DNA were obtained from Fluka AG, Buchs SG,
Switzerland. Corn oil, purchased in a local retail shop, was from Kentaur-Nuxo
AG, Burgdorf Switzerland.
Animals and treatments
Male CitCryBR rats and male B6C3Fl/CrIBR mice from Charles River Wiga,
Sulzfeld FRG were used. They were acclimatized in Macrolon cages for at least
1 week after delivery and were fed ad libitum with tap water and maintenance
diet NAFAG 890, purchased from Nafag AG, Gossau SG, Switzerland.
Application solutions
The ampoule containing the radiolabeled compound was cooled at the bottom
with liquid nitrogen and cut open. [7-3H]SO was dissolved in DMSO and,
depending on the required chemical dose, unlabeled SO was added. The solution
was transferred into a glass test tube and diluted with corn oil. The ratio
DMSO/SO/corn oil was 1:1:4, 1:250:1500 and 1:1:18, for the experiments with
rats at high and low dose, and with mice respectively.
The radioactivity in the application solution was determined by scintillation
counting of an aliquot diluted into toluene.
The unfasted rats received - 0.5 ml of the application solution by oral gavage
early in the morning. The exact dose was determined by the weight difference
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of the syringe and is shown in Table I. Control rats received 0.5 ml com oil.
Four mice received - 70 fil of the application solution by i.p. administration,
resulting in a mean dose of 165 mg/kg (3.2 x 109 d.p.m./kg). Two control mice
received 200 p\ corn oil.
The rats were killed with ether 4 or 24 h after the administration. The mice
were killed with ether 2 h after the administration. Organs of interest were excised,
pooled into groups of three (except for the liver) and kept frozen at — 20°C.
Isolation of DNA and chromatin protein
DNA and chromatin protein were isolated from selected organs via a chromatin
fraction according to Sagelsdorff « al. (11). The DNA of the 24 h/low dose was
repetitively purified according to Sagelsdorff et al. (11). The DNA from the other
experiments was rcpurifkd by hydroxyapante (HA) adsorption chromatography:dry
HA (1 g/mg DNA) was suspended overnight in filtered MUP (8 M urea, 0.24
M sodium phosphate buffer, pH 6.8), the slurry was swirled and poured into
a 25 X 120 mm glass column and the MUP was allowed to run off. The DNA
solution was loaded on the column and the elution monitored at 260 run. The
column was washed with MUP at a flow rate of 1 - 2 ml/rrun by gravity until
the absorbance had returned to background value. The urea was then purged with
14 mM sodium phosphate, pH 6.8, and the DNA eluted with 0.48 mM sodium
phosphate, pH 6.8. The collected eluate was dialyzed at 4°C against 2 x 10 I
0.2 M sodium chloride for 12 and 24 h. The DNA concentration, as determined
by optical density, was usually high enough for direct scintillation counting.
Control experiments were performed using DNA isolated from untreated
animals. The radioactivity counts—upon comparison with historical controls—
were used to show that the work-up of the DNA samples was performed without
external contamination with radiolabel.
In vitro incubation of calf thymus DNA with [7-3H]SO
Calf thymus DNA was purified according to the method described above in order
to remove residual protein. A 220 fii (150 f»Ci) portion of the application solution
remaining from the rat 24 h/low dose experiment and 500 p\ 1 % SDS in 14 mM
sodium phosphate, pH 6.8, were added to 14 mg calf thymus DNA dissolved
in 10 ml 8 mM calcium chloride, 20 mM sodium succinate, pH 6.0. The mixture
was incubated for 24 h at 37°C, 20 ml ethanol was added and the solution kept
at -20°C for 4 days. The precipitated DNA was centrifuged at 1000 g, the
supernatant discarded, and the pellet redissolved in 26 ml calcium succinate buffer.
The solution was dialyzed overnight against 10 1 0.2 M sodium chloride, extracted
twice wim phenol/chloroform/isoamyl alcohol (25:25:1) and twice with ether to
remove phenol, and was dialyzed again. The DNA was precipitated with ethanol
and kept at -20°C for 3 weeks, centrifuged at 1000 g, the supernatant discarded,
and the pellet dissolved in 15 ml calcium succinate buffer. The optical density
and the specific activity were measured.
The DNA was purified repetitively (four times) by ethanol precipitation and
dialysis to constant specific activity.
HPLC analysis of the nucleotides
DNA was digested according to Sagelsdorff et al. (12). The resulting
deoxynucleotides were separated by HPLC on an Eurosphere RP18 5fi column
(250 x 4 mm) with a flow of 2 ml/min 30 mM ammonium formate buffer,
pH 3.8/2% methanol for 15 min, followed by a gradient of 2-60% methanol
in 25 min, 60-2% methanol in 10 min and 2% methanol for 15 min. The optical
density of the eluate was recorded at 254 nm. Two minute fractions of digested
in vitro DNA were collected. Based on optical density and radioactivity patterns,
six fractions of digested in vivo DNA were collected. Fraction 1 (0-2 min):
front; fraction 2 (2-10 min): natural nudeoades; fraction 3 (10-16 min): between
natural nucleotides and adducts; fraction 4 (16-26 min): adducts; fraction 5
(26-36 min): adducts; fraction 6 (36—46 min): after adducts. The fractions were
freeze-dricd, dissolved in 1 ml water and counted.
Scintillation counting
DNA samples were counted in 10 ml Instaget* (Packard) for 3 x 30 min. The
significance level at 2 standard deviations, given by the Poisson distribution of
the radioactive decay plus vial-to-vial differences, had been determined to be
2.6 c.p.m. in the tritium channel. The counting efficiency ranged between 28
and 32%.
The nucleotide fractions from the HPLC analyses were counted in 10 ml Ultima
Gold® (Packard) in plastic vials for 45 mm. The significance level had been
determined to be 1.0 c.p.m. in an optimized tritium channel. The counting
efficiency was 48%. The net radioactivity was calculated by subtracting the
radioactivity of an equivalent sample isolated from animals treated with vehicle
only, both for DNA samples and for fractions of the nucleotides analyses.
Calculations
The concentration of a DNA solution was calculated from the optical density
of a diluted aliquot at 260 nm using an absorbance of 20 for 1 mg DNA/ml.
Depending on the amount of DNA available, an aliquot corresponding to
0 25 -1 mg DNA was taken, diluted with calcium succinate buffer to a
standardized concentration (usually the concentration of the most diluted sample
of the ongoing experiment), added to 10 ml Instagel, and counted.
The concentration of the nucleotide solutions was calculated from the optical
density of a diluted aliquot at 260 nm using an absorbance of 35 for a nucleotide
mixture equivalent to 1 mg digested DNA/ml. The specific DNA radioactivity
was expressed as DNA binding per dose administered, by conversion to the units
of the covalent binding index, CBI = /imol SO bound per mol DNA
nucleotide/mmol SO administered per kg body wt (13).
Table I. Investigation of the
Dose* (mg/kg)
(10* d.p.m./kg)
DNA sp. act
first purification
(d.p.m./mg)
(CBI units)b
Repetitive purification
(d.p.m./mg)
(CBI units)
Nucleotide analysis
Recovery of
optical density (%)
Radioactivity
eluting with
optical density (%)
Radioactivity
eluting without
optical density (%)
Covalent DNA binding
(CBI units)
covalent binding
Time/dose
4 h/low dose
1.65
3.17
49.9
<28.8
<2.8
of [7-3H]SO
1.78
3.42
57.8
<28.8
<2.6
to DNA isolated from the forestomach of male CD rats after oral
4 h/high dose 24 h/low dose
232 255 1.66 1.52
2.11 2.33 3.23 2.90
62.9 94.8 53.5 35.2
£5.1 £3.7
<22.8 <39.4
<3.4 <5.3
administration
24 h/high dose
242
2.21
170.5
51.2
76
66
<34
<6.5
218
1.98
75.9
24.4
ND
71
<29
<2.5
"Means of pools of three rats.
bCBl unit defined as DNA binding per dose: CBI = (/imol chemical bound/mol DNA nucleotide)/(mmol chemical administered/kg body wt).
cNo DNA left in 24 h/low dose samples.
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Results
Reaction of[7-3H]SO with DNA in vitro
The aim of this study was to investigate the DNA binding potency
of SO in vivo. For the analysis of DNA isolated from animal
organs, therefore, the chromatographic properties of SO—nucleo-
tide adducts had to be known from in vitro reactions.
Incubation of tritiated SO with DNA in vitro resulted in a DNA
that contained irreversibly bound radioactivity. On the basis of
the specific activity of SO used, the level of DNA adducts was
calculated to be 10 SO-nucleotide adducts/106 nucleotides. The
fraction of SO that had reacted with DNA under these conditions
was as little as 0.03%, indicating the low electrophilic reactivity
of this epoxide.
Enzymatic degradation of the DNA and separation of the
3'-nucleotides by HPLC revealed that the radioactivity eluted
distant from the normal nucleotides and nucleosides (Figure 1).
In agreement with the literature (7), a number of different
SO—nucleotide adducts must be expected.
In vivo DNA binding of SO in the rat after oral administration
In the first set of in vivo experiments, rats were treated by oral
gavage at two dose levels. The high dose corresponded to a dose
used in the carcinogenicity bioassays; the low dose was > 100
times lower and was used to investigate any dose-dependent
differences in SO metabolism. DNA was analyzed 4 or 24 h post-
dosage. According to the kinetics established, all SO is expected
to be absorbed and metabolized within 4 h (9). At this time point,
DNA binding is dierefore expected to be close to its maximum
value. The 24 h point was taken to show the rate of removal
and repair of putative DNA adducts.
The purification of DNA from non-covalently bound radio-
activity is crucial in this type of experiment when up to half a
millicurie are administered per animal. Therefore, whenever a
DNA sample contained measurable radioactivity and enough
DNA was available, purification was repeated until constant
specific activity was reached.
Table I summarizes the data obtained from the target organ
for tumor induction, the forestomach. At 4 h after the administra-
tion, the DNA did not contain measurable radioactivity. Using
our limit of detection of 2.6 c.p.m. radioactivity per glass
cpm
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Fig. 1. Reverse-phase HPLC profiles of optical density (solid line) and
tritium radioactivity (bars; c.p.m.) of deoxyribonucleotides obtained by
enzymatic hydrolysis of calf thymus DNA after incubation with [7-3H]SO.
scintillation vial, the DNA binding potency, expressed in the units
of the CBI, was <2.6. At 24 h post-dosage, radioactivity was
detectable in all DNA samples. It is highly unlikely that this
radioactivity can be attributed to DNA adduct formation, because
all SO administered should have been metabolized within the first
4 h. No additional adducts are therefore expected to be formed
between 4 and 24 h. The radioactivity detected after 24 h more
likely represents biosynthetic incorporation of radiolabel into
newly synthesized DNA. For instance, tritiated water is formed
when the tritium label of me 7-position of the tritiated SO is
released during the oxidation of mandelic acid to benzoic acid
or phenylglyoxylic acid. A tritium atom can be incorporated into
DNA when, for instance, the hydroxyl group in the 2'-position
of the ribonucleotides is replaced by a hydrogen atom to form
the 2'-deoxyribonucleotides.
In order to show positively the biosynthetic incorporation of
radiolabel into the normal nucleotides, DNA isolated from the
forestomach, 24 h after administration of the high dose of SO,
was degraded to the 3'-nucleotides, which were analyzed by
HPLC (Figure 2). All detectable radioactivity eluted together with
the normal nucleotides. No significant radioactivity was seen at
elution times known for the adducts formed in vitro between SO
and DNA. The Limit of detection shown in the last column of
Table I was calculated on the assumption that an adduct could
be divided into two fractions (2 c.p.m.).
In the glandular stomach (which was not a target organ for
tumor induction), the situation was similar to the forestomach.
Thanks to the higher yield to DNA from this portion of
the stomach, the limit of detection to exclude DNA adduct
formation was even somewhat better than in the forestomach
(CBI < 1.5). Again, in all DNA samples that were detectably
radiolabeled (4 h/low dose and 24 h/high dose), the DNA radio-
activity was localized in the fractions containing the normal
nucleotides (data not shown). The resulting limit of detection of
DNA adduct formation was at CBI < 1.0.
In the DNA isolated from the livers, the first purification round
already resulted in a limit of detection CBI < 2 in all but the
24 h/low dose sample. In this sample, repetitive purification
removed the residual DNA-associated radioactivity and a Limit
of detection of CBI < 0.6 was derived from counting all available
DNA sample.
In vivo DNA binding of SO in the mouse after i.p. administration
While SO is quite stable in neutral aqueous media, the hydrolysis
is much faster in acid (9). It is therefore conceivable that orally
cpm
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10 20 30 40 Time/min
Fig. 2. Reverse-phase HPLC profiles of optical density (solid line) and
tritium radioactivity (bars; c.p.m.) of deoxyribonucleotides obtained by
enzymatic hydrolysis of DNA isolated from the forestomachs of a pool of
three male CrhCD^BR rats 24 h after p.o. administration of 2.2 x 109
d.p.m./kg (242 mg/kg) [7-3H]SO.
195
S.Cantoreggl and W.K-Lutz
administered SO is hydrolyzed to a certain extent in the stomach
so that the dose reaching the liver is only a fraction of the
administered dose. The limit of detection of DNA binding in the
liver would then not be as low as indicated because the CBI
expresses DNA damage per dose.
In a second experiment, therefore, SO was administered by
i.p. injection in order to circumvent the acidic milieu of the
stomach. Mice were used for this experiment and the period of
observation was 2 h so that the data are directly comparable with
the data published by Nordqvist et al. (8).
No DNA sample isolated from the liver contained measurable
DNA radioactivity after the first purification round. In CBI units,
upper limit values of 0.6 resulted. This value supports our
negative data obtained in the rat but is ~ 40 times lower than
the CBI value for mouse liver DNA estimated from one
chromatogram shown in the paper of Nordqvist et al. (8).
Discussion
SO did not produce detectable DNA adducts in the target organ
for tumor induction. The limit of detection in the low-dose
experiment was at 7 adducts/108 nucleotides in the forestomach
DNA. In vitro, after a 24 h incubation of tritiated SO with calf
thymus DNA, adducts had been formed to a minor but
measurable extent. It is therefore probable that a few adducts
will have been formed in vivo also. The question is whether
these few DNA adducts below the limit of detection can be
responsible for the tumors induced in the forestomach after
chronic oral gavage of SO.
In the carcinogenicity studies, toxicity and regenerative
hyperplasia have been observed in the forestomach (5). Stimulated
cell division is being discussed increasingly as a cause of cancer
by itself (10) under the assumption that it accelerates the
accumulation of mutations from spontaneous DNA damage (14).
An increased tumor incidence is therefore possible in the absence
of a DNA-damaging chemical.
The above discussion is valid only if two requirements are met.
Firstly, adducts formed in vivo must be chemically stable during
DNA purification. Some guanyl-7 adducts are known to be
chemically labile, especially at acid pH. For the respective SO
adducts in the form of mononucleotides, the half-life has been
described to be ~ 4 h (16). In double-stranded DNA, however,
these adducts were considered 'not particularly labile', on the
basis of a half-life of 10 days at pH 4.2 and room temperature
(7). Furthermore, about one-quarter of the adducts are formed
at positions other than the 7-nitrogen of guanine and are
chemically stable (7). At the worst, therefore, our limit of
detection has to be multiplied by a factor of 4, under the extreme
assumption that all guanyl-7 adducts are lost during DNA
purification.
Secondly, the limit of detection must be below the CBI of
comparable genotoxic carcinogens. For instance, 1,2-dichloro-
ethane produced forestomach tumors in rats after administration
by oral gavage with a carcinogenic potency similar to that of SO
(17). On the other hand, DNA-binding experiments reported by
Reitz et al. (18) showed CBI values of 7 in the stomach and 18
in the liver, i.e. DNA-binding potencies higher than our limit
of detection for SO by a factor of > 5 to >30. This indicates
that the carcinogenic potency of SO is probably based on
promoting factors acting in addition to an undetectable DNA-
binding potency. This discussion holds only if the pattern of DNA
adducts formed by SO and 1,2-dichloroethane have similar
mutational consequences. This question cannot be addressed
experimentally if the level of adducts is below the limit of
detection. The possibility that an undetectable DNA adduct is
extremely dangerous is small but can never be excluded.
It is concluded that a purely genotoxic mechanism of
tumorigenic action of SO is unlikely. The observed tumorigenic
potency in the forestomach is probably the result of strong tumor
promotion by regenerative hyperplasia.
The question now arises whether these data can also be used
to interpret the carcinogenicity studies with styrene. SO is the
main intermediate metabolite of styrene. The relative stability
of SO towards DNA could therefore indicate that the parent
compound styrene cannot show a high CBI, either. However,
a minor fraction of the styrene metabolism (< 1 %) involves the
formation of 4-vinylphenol, probably via an intermediate
3,4-epoxide (19,20). The DNA-binding potency of this epoxide
is not known. It is further not known whether SO formed from
styrene intracellularly can result in a higher concentration near
DNA than SO entering from outside. Therefore, DNA binding
studies with styrene will have to be performed to interpret in a
manner similar to SO the carcinogenicity studies with the parent
compound styrene.
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